Guanhao Biotech Co.,Ltd. (SHE:300238)
China · Delayed Price · Currency is CNY 15.01
-0.33 (-2.15%)
Apr 21, 2026, 3:04 PM CST
Guanhao Biotech Market Cap
Guanhao Biotech has a market cap or net worth of 3.98 billion as of April 21, 2026. Its market cap has increased by 10.86% in one year.
Market Cap
3.98B
Enterprise Value
3.86B
Revenue
387.75M
Ranking
n/a
PE Ratio
166.78
Stock Price
15.01
Market Cap Chart
Since July 6, 2011, Guanhao Biotech's market cap has increased from 2.74B to 3.98B, an increase of 45.04%. That is a compound annual growth rate of 2.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 3.98B | 8.38% |
| Dec 31, 2025 | 3.67B | 15.03% |
| Dec 31, 2024 | 3.19B | -11.21% |
| Dec 29, 2023 | 3.60B | 31.91% |
| Dec 30, 2022 | 2.73B | -44.52% |
| Dec 31, 2021 | 4.91B | -26.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hefei Lifeon Pharmaceutical | 4.55B |
| Shanghai Obio Technology (Group) Corp. | 4.51B |
| Hinova Pharmaceuticals | 4.49B |
| Pulike Biological Engineering | 4.32B |
| Shanghai Serum Bio-Technology | 4.14B |
| Boji Medical Technology | 3.95B |
| Baolingbao Biology | 3.92B |
| Zhejiang Wecome Pharmaceutical Company | 3.88B |